International Biotechnology Trust plc
Portfolio Analysis
30 April 2013 |
Summary
IBT Portfolio NAV (m)
£154.8
Number of Portfolio Companies
70
Quoted Investments
43
Unquoted Investments
27
Quoted / Unquoted Split
NAV by Geography
Quoted
81%
United States / Canada
88%
Unquoted
16%
Europe
9%
Cash
3%
Australia
0%
Total
100%
Cash
3%
Total
100%
NAV by Subsector
NAV by Market Capitalisation
Therapeutics
73%
Large-Cap (>$10bn)
32%
Medical Devices
7%
Mid-Cap (>$1bn, <$10bn)
29%
Specialty Pharma
6%
Small-Cap (<$1bn)
19%
Life Sciences, Tools
11%
Unquoted
16%
Cash
3%
Cash
1%
Total
100%
Total
100%
NAV by Development Phase
Marketed
53%
Regulatory
2%
Phase 3
10%
Phase 2
10%
Phase 1
3%
Other
19%
Cash
3%
Total
100%